305 related articles for article (PubMed ID: 34447995)
1. Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial.
Willems S; Borof K; Brandes A; Breithardt G; Camm AJ; Crijns HJGM; Eckardt L; Gessler N; Goette A; Haegeli LM; Heidbuchel H; Kautzner J; Ng GA; Schnabel RB; Suling A; Szumowski L; Themistoclakis S; Vardas P; van Gelder IC; Wegscheider K; Kirchhof P
Eur Heart J; 2022 Mar; 43(12):1219-1230. PubMed ID: 34447995
[TBL] [Abstract][Full Text] [Related]
2. Early rhythm-control therapy for atrial fibrillation in patients with a history of stroke: a subgroup analysis of the EAST-AFNET 4 trial.
Jensen M; Suling A; Metzner A; Schnabel RB; Borof K; Goette A; Haeusler KG; Zapf A; Wegscheider K; Fabritz L; Diener HC; Thomalla G; Kirchhof P
Lancet Neurol; 2023 Jan; 22(1):45-54. PubMed ID: 36517170
[TBL] [Abstract][Full Text] [Related]
3. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.
Kirchhof P; Camm AJ; Goette A; Brandes A; Eckardt L; Elvan A; Fetsch T; van Gelder IC; Haase D; Haegeli LM; Hamann F; Heidbüchel H; Hindricks G; Kautzner J; Kuck KH; Mont L; Ng GA; Rekosz J; Schoen N; Schotten U; Suling A; Taggeselle J; Themistoclakis S; Vettorazzi E; Vardas P; Wegscheider K; Willems S; Crijns HJGM; Breithardt G;
N Engl J Med; 2020 Oct; 383(14):1305-1316. PubMed ID: 32865375
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial.
Metzner A; Suling A; Brandes A; Breithardt G; Camm AJ; Crijns HJGM; Eckardt L; Elvan A; Goette A; Haegeli LM; Heidbuchel H; Kautzner J; Kuck KH; Mont L; Ng GA; Szumowski L; Themistoclakis S; van Gelder IC; Vardas P; Wegscheider K; Willems S; Kirchhof P
Europace; 2022 Apr; 24(4):552-564. PubMed ID: 34473249
[TBL] [Abstract][Full Text] [Related]
5. Generalizability of the EAST-AFNET 4 Trial: Assessing Outcomes of Early Rhythm-Control Therapy in Patients With Atrial Fibrillation.
Dickow J; Kirchhof P; Van Houten HK; Sangaralingham LR; Dinshaw LHW; Friedman PA; Packer DL; Noseworthy PA; Yao X
J Am Heart Assoc; 2022 Jun; 11(11):e024214. PubMed ID: 35621202
[TBL] [Abstract][Full Text] [Related]
6. Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure.
Rillig A; Magnussen C; Ozga AK; Suling A; Brandes A; Breithardt G; Camm AJ; Crijns HJGM; Eckardt L; Elvan A; Goette A; Gulizia M; Haegeli L; Heidbuchel H; Kuck KH; Ng A; Szumowski L; van Gelder I; Wegscheider K; Kirchhof P
Circulation; 2021 Sep; 144(11):845-858. PubMed ID: 34328366
[TBL] [Abstract][Full Text] [Related]
7. Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.
Kirchhof P; Breithardt G; Camm AJ; Crijns HJ; Kuck KH; Vardas P; Wegscheider K
Am Heart J; 2013 Sep; 166(3):442-8. PubMed ID: 24016492
[TBL] [Abstract][Full Text] [Related]
8. Presenting Pattern of Atrial Fibrillation and Outcomes of Early Rhythm Control Therapy.
Goette A; Borof K; Breithardt G; Camm AJ; Crijns HJGM; Kuck KH; Wegscheider K; Kirchhof P;
J Am Coll Cardiol; 2022 Jul; 80(4):283-295. PubMed ID: 35863844
[TBL] [Abstract][Full Text] [Related]
9. Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry.
Proietti M; Vitolo M; Harrison SL; Lane DA; Fauchier L; Marin F; Nabauer M; Potpara TS; Dan GA; Boriani G; Lip GYH;
Clin Res Cardiol; 2022 Jan; 111(1):70-84. PubMed ID: 34448931
[TBL] [Abstract][Full Text] [Related]
10. Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden.
Rillig A; Borof K; Breithardt G; Camm AJ; Crijns HJGM; Goette A; Kuck KH; Metzner A; Vardas P; Vettorazzi E; Wegscheider K; Zapf A; Kirchhof P
Circulation; 2022 Sep; 146(11):836-847. PubMed ID: 35968706
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of long-term sodium channel blocker therapy for early rhythm control: the EAST-AFNET 4 trial.
Rillig A; Eckardt L; Borof K; Camm AJ; Crijns HJGM; Goette A; Breithardt G; Lemoine MD; Metzner A; Rottner L; Schotten U; Vettorazzi E; Wegscheider K; Zapf A; Heidbuchel H; Willems S; Fabritz L; Schnabel RB; Magnussen C; Kirchhof P
Europace; 2024 Jun; 26(6):. PubMed ID: 38702961
[TBL] [Abstract][Full Text] [Related]
12. Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank.
Kany S; Cardoso VR; Bravo L; Williams JA; Schnabel R; Fabritz L; Gkoutos GV; Kirchhof P
Heart; 2022 Nov; 108(23):1873-1880. PubMed ID: 35835543
[TBL] [Abstract][Full Text] [Related]
13. Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial.
Eckardt L; Sehner S; Suling A; Borof K; Breithardt G; Crijns H; Goette A; Wegscheider K; Zapf A; Camm J; Metzner A; Kirchhof P
Eur Heart J; 2022 Oct; 43(40):4127-4144. PubMed ID: 36036648
[TBL] [Abstract][Full Text] [Related]
14. Early Rhythm Control Therapy for Atrial Fibrillation in Low-Risk Patients : A Nationwide Propensity Score-Weighted Study.
Kim D; Yang PS; You SC; Jang E; Yu HT; Kim TH; Pak HN; Lee MH; Lip GYH; Sung JH; Joung B
Ann Intern Med; 2022 Oct; 175(10):1356-1365. PubMed ID: 36063552
[TBL] [Abstract][Full Text] [Related]
15. Rate versus rhythm control for atrial fibrillation: from AFFIRM to EAST-AFNET 4 - a paradigm shift.
Roman S; Patel K; Hana D; Guice KC; Patel J; Stadnick C; Basta A; Khouzam RN
Future Cardiol; 2022 Apr; 18(4):354-353. PubMed ID: 35255732
[TBL] [Abstract][Full Text] [Related]
16. Clinical Outcomes of Rhythm Control Strategies for Asymptomatic Atrial Fibrillation According to the Quality-of-Life Score: The CODE-AF (Comparison Study of Drugs for Symptom Control and Complication Prevention of Atrial Fibrillation) Registry.
Kim JY; Park HS; Park HW; Choi EK; Park JK; Kim JB; Kang KW; Shim J; Joung B; Park KM
J Am Heart Assoc; 2022 Sep; 11(18):e025956. PubMed ID: 36073646
[TBL] [Abstract][Full Text] [Related]
17. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.
Packer DL; Mark DB; Robb RA; Monahan KH; Bahnson TD; Poole JE; Noseworthy PA; Rosenberg YD; Jeffries N; Mitchell LB; Flaker GC; Pokushalov E; Romanov A; Bunch TJ; Noelker G; Ardashev A; Revishvili A; Wilber DJ; Cappato R; Kuck KH; Hindricks G; Davies DW; Kowey PR; Naccarelli GV; Reiffel JA; Piccini JP; Silverstein AP; Al-Khalidi HR; Lee KL;
JAMA; 2019 Apr; 321(13):1261-1274. PubMed ID: 30874766
[TBL] [Abstract][Full Text] [Related]
18. Association of genetic risk and outcomes in patients with atrial fibrillation: interactions with early rhythm control in the EAST-AFNET4 trial.
Kany S; Al-Taie C; Roselli C; Pirruccello JP; Borof K; Reinbold C; Suling A; Krause L; Reissmann B; Schnabel RB; Zeller T; Zapf A; Wegscheider K; Fabritz L; Ellinor PT; Kirchhof P
Cardiovasc Res; 2023 Aug; 119(9):1799-1810. PubMed ID: 37264683
[TBL] [Abstract][Full Text] [Related]
19. Early Rhythm Control and the Risks of Ischemic Stroke, Heart Failure, Mortality, and Adverse Events When Performed Early (<3 Months): A Nationwide Cohort Study of Newly Diagnosed Patients with Atrial Fibrillation.
Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
Thromb Haemost; 2022 Nov; 122(11):1899-1910. PubMed ID: 35322396
[TBL] [Abstract][Full Text] [Related]
20. [Update atrial fibrillation: the 2020 ESC guidelines and recent data on early rhythm control].
Schleberger R; Rillig A; Kirchhof P; Metzner A; Reissmann B
Herzschrittmacherther Elektrophysiol; 2021 Jun; 32(2):257-263. PubMed ID: 33783622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
